1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
CAS: 74389-68-7
Ref. 01-4006552
25mg | 163.00 € | ||
100mg | 421.00 € | ||
500mg | 1,518.00 € |
Product Information
- PAF (C₁₆)
- (2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
- 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
- 1-O-Hexadecyl-2-Acetyl-Sn-Glycero-3-Phosphocholine
- 1-O-Hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-Hexadecyl-2-acetyl-sn-glycerophosphocholine
- 1-O-Hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine
- 1-O-Hexadecyl-platelet-activating factor
- 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (7R)-
- 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-
- See more synonyms
- Blood platelet-activating factor
- Blood platelet-activating factor acether
- C<sub>16</sub>-PAF
- C<sub>16</sub>-PAF acether
- Ethanaminium, 2-[[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl]oxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt
- PAF acether
- Paf 16
- Paf C 16
- Platelet-activating factor
- Platelet-activating factor (1-O-hexadecyl)
- Platelet-activating factor acether
Accelerated cognitive decline in Alzheimer’s patients is associated with accumulation of choline-containing phospholipids. One of them, C16-PAF, is specifically elevated in brains of Alzheimer’s patients. Enhanced exposure to this platelet-activating factor ultimately leads to neuronal death.
Chemical properties
Technical inquiry about: 01-4006552 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.